Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hand Hygiene | 2 | 2019 | 18 | 0.590 |
Why?
|
| Anti-Bacterial Agents | 4 | 2026 | 2576 | 0.550 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 153 | 0.530 |
Why?
|
| Bacterial Infections | 1 | 2019 | 326 | 0.470 |
Why?
|
| Joint Prosthesis | 1 | 2013 | 17 | 0.410 |
Why?
|
| Infection Control | 1 | 2015 | 163 | 0.400 |
Why?
|
| Shoulder Joint | 1 | 2013 | 31 | 0.400 |
Why?
|
| Aortitis | 1 | 2013 | 7 | 0.390 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2013 | 92 | 0.390 |
Why?
|
| Meningitis | 1 | 2013 | 98 | 0.380 |
Why?
|
| Haemophilus Infections | 1 | 2013 | 97 | 0.370 |
Why?
|
| Haemophilus influenzae | 1 | 2013 | 135 | 0.370 |
Why?
|
| Guideline Adherence | 1 | 2015 | 393 | 0.360 |
Why?
|
| Cross Infection | 1 | 2015 | 339 | 0.350 |
Why?
|
| Prosthesis-Related Infections | 1 | 2013 | 194 | 0.340 |
Why?
|
| Marfan Syndrome | 1 | 2013 | 147 | 0.340 |
Why?
|
| Escherichia coli Infections | 1 | 2013 | 195 | 0.340 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 941 | 0.330 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 537 | 0.280 |
Why?
|
| Gram-Negative Bacteria | 1 | 2026 | 76 | 0.230 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2026 | 95 | 0.230 |
Why?
|
| Vibrio vulnificus | 1 | 2005 | 6 | 0.230 |
Why?
|
| Fallopian Tube Diseases | 1 | 2005 | 6 | 0.230 |
Why?
|
| Vibrio Infections | 1 | 2005 | 16 | 0.220 |
Why?
|
| Ovarian Diseases | 1 | 2005 | 24 | 0.220 |
Why?
|
| Ribavirin | 1 | 2004 | 86 | 0.210 |
Why?
|
| Granuloma | 1 | 2004 | 63 | 0.210 |
Why?
|
| Interferons | 1 | 2004 | 136 | 0.210 |
Why?
|
| Abscess | 1 | 2005 | 137 | 0.200 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2004 | 176 | 0.190 |
Why?
|
| Bacteremia | 1 | 2026 | 428 | 0.180 |
Why?
|
| Hepatitis C | 1 | 2004 | 390 | 0.170 |
Why?
|
| Disease Notification | 1 | 2020 | 9 | 0.160 |
Why?
|
| Patient Isolation | 1 | 2019 | 15 | 0.150 |
Why?
|
| Antiviral Agents | 1 | 2004 | 813 | 0.150 |
Why?
|
| Disinfection | 1 | 2019 | 26 | 0.150 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 501 | 0.130 |
Why?
|
| Antimicrobial Stewardship | 1 | 2019 | 89 | 0.130 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2022 | 500 | 0.130 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 293 | 0.130 |
Why?
|
| Catheter-Related Infections | 1 | 2019 | 137 | 0.130 |
Why?
|
| Influenza, Human | 1 | 2022 | 704 | 0.120 |
Why?
|
| Disease Eradication | 1 | 2015 | 40 | 0.110 |
Why?
|
| Ebolavirus | 1 | 2015 | 46 | 0.110 |
Why?
|
| Pneumonia | 1 | 2019 | 344 | 0.110 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 58 | 0.110 |
Why?
|
| Hemolysin Proteins | 1 | 2014 | 29 | 0.110 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2014 | 34 | 0.110 |
Why?
|
| Sepsis | 1 | 2019 | 501 | 0.110 |
Why?
|
| Urinary Tract Infections | 1 | 2019 | 328 | 0.110 |
Why?
|
| Shoulder Dislocation | 1 | 2013 | 9 | 0.100 |
Why?
|
| Synovial Fluid | 1 | 2013 | 17 | 0.100 |
Why?
|
| Bacterial Toxins | 1 | 2014 | 171 | 0.100 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 314 | 0.100 |
Why?
|
| Arthroplasty, Replacement | 1 | 2013 | 27 | 0.100 |
Why?
|
| Debridement | 1 | 2013 | 90 | 0.100 |
Why?
|
| Humans | 14 | 2026 | 131781 | 0.100 |
Why?
|
| Prosthesis Failure | 1 | 2013 | 148 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1165 | 0.090 |
Why?
|
| Immunocompromised Host | 1 | 2014 | 313 | 0.090 |
Why?
|
| Radiography, Thoracic | 1 | 2013 | 147 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2014 | 234 | 0.090 |
Why?
|
| Renal Dialysis | 1 | 2019 | 952 | 0.090 |
Why?
|
| Middle Aged | 5 | 2020 | 28897 | 0.080 |
Why?
|
| Anti-Infective Agents | 1 | 2013 | 265 | 0.080 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 485 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 301 | 0.080 |
Why?
|
| Female | 9 | 2022 | 71221 | 0.080 |
Why?
|
| Reoperation | 1 | 2013 | 844 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 2014 | 569 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1912 | 0.070 |
Why?
|
| Aspergillus flavus | 1 | 2005 | 2 | 0.060 |
Why?
|
| Scleritis | 1 | 2005 | 10 | 0.060 |
Why?
|
| Peptides, Cyclic | 1 | 2005 | 49 | 0.060 |
Why?
|
| Aspergillosis | 1 | 2005 | 46 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2013 | 12997 | 0.060 |
Why?
|
| Eye Infections, Fungal | 1 | 2005 | 68 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 2122 | 0.060 |
Why?
|
| Triazoles | 1 | 2005 | 144 | 0.050 |
Why?
|
| Drainage | 1 | 2005 | 253 | 0.050 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2026 | 398 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2026 | 853 | 0.050 |
Why?
|
| RNA, Messenger, Stored | 1 | 2022 | 6 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2005 | 445 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 1171 | 0.040 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 321 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 3917 | 0.040 |
Why?
|
| Epidemiological Monitoring | 1 | 2020 | 69 | 0.040 |
Why?
|
| Seasons | 1 | 2020 | 333 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 530 | 0.030 |
Why?
|
| Adult | 3 | 2022 | 31710 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 3094 | 0.030 |
Why?
|
| Liberia | 1 | 2015 | 9 | 0.030 |
Why?
|
| Poverty Areas | 1 | 2015 | 36 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 5297 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2005 | 3696 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2026 | 6509 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2022 | 3451 | 0.030 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2014 | 22 | 0.030 |
Why?
|
| Fiber Optic Technology | 1 | 2014 | 45 | 0.030 |
Why?
|
| Bronchi | 1 | 2014 | 102 | 0.030 |
Why?
|
| Aged | 2 | 2020 | 21263 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2014 | 179 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 2695 | 0.020 |
Why?
|
| Texas | 1 | 2020 | 3622 | 0.020 |
Why?
|
| Health Personnel | 1 | 2015 | 550 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7575 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6916 | 0.020 |
Why?
|
| United States | 1 | 2022 | 11815 | 0.020 |
Why?
|
| Lung | 1 | 2014 | 1566 | 0.020 |
Why?
|
| Voriconazole | 1 | 2005 | 30 | 0.010 |
Why?
|
| Lipopeptides | 1 | 2005 | 35 | 0.010 |
Why?
|
| Echinocandins | 1 | 2005 | 42 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2005 | 298 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17667 | 0.010 |
Why?
|
| Male | 2 | 2020 | 65290 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 34402 | 0.010 |
Why?
|